Funds holding ADAGIO MEDICAL HOLDINGS INC
ISIN US00534B1008 · United States
- Fund holders
- 6
- Of which ETFs
- 0 6 other funds
- Value held
- ≈ 129.3K $ 111.4K $ · 15.3K €
- Share of capital
- 0.5 % of 22.2M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 51,349 | 51.3K $ | 0.00 % | 0.23 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 35,426 | 40.7K $ | 0.16 % | as of Mar 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 9,229 | 9.2K $ | 0.04 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 5,436 | 5.4K $ | 0.02 % | as of Feb 28, 2026 ↗ | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 4,000 | 4.6K $ | 0.02 % | as of Mar 31, 2026 ↗ | |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 15.3K € | 0.02 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.02 % | as of Dec 31, 2025 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 5 | 0 | 105,440 | +76.5 % |
| 2026Q1 | 5 | +1 | 59,752 | +6.7 % |
| 2025Q4 | 4 | +1 | 55,988 | +62.3 % |
| 2025Q3 | 3 | 0 | 34,486 | +44.3 % |
| 2025Q2 | 3 | 0 | 23,897 | +5.0 % |
| 2025Q1 | 3 | +2 | 22,752 | +199.0 % |
| 2024Q4 | 1 | 7,609 |
Institutional managers
21 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 9,876,576 | 11M $ | as of Mar 31, 2026 |
| Sio Capital Management, LLC | 1,288,461 | 1.5M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,258,501 | 1.4M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 1,205,447 | 1.4M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 1,159,615 | 1.3M $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 251,972 | 289.8K $ | as of Mar 31, 2026 |
| Shaolin Capital Management LLC | 171,170 | 196.8K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 125,241 | 144K $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 80,000 | 92K $ | as of Mar 31, 2026 |
| Granite Investment Partners, LLC | 27,053 | 31.1K $ | as of Mar 31, 2026 |
| TORONTO DOMINION BANK | 25,000 | 28.8K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 23,350 | 26.9K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 21,598 | 24.8K $ | as of Mar 31, 2026 |
| Opaleye Management Inc. | 18,444 | 21.2K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 16,557 | 19K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 12,857 | 14.8K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 2,202 | 2.5K $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 975 | 1.1K $ | as of Mar 31, 2026 |
| Crewe Advisors LLC | 500 | 575 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 137 | 158 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1 | 1 $ | as of Mar 31, 2026 |
Declared shareholders of ADAGIO MEDICAL HOLDINGS INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Perceptive Advisors LLC and 3 others | 55.40 % | 15,321,655 | as of Mar 31, 2026 · SCHEDULE 13G |
| Adage Capital Management, L.P. and 2 others | 5.67 % | 1,258,501 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding ADAGIO MEDICAL HOLDINGS INC". https://titelia.com/en/stocks/adagio-medical-holdings-inc-US00534B1008